Walman Optical, ADO Practice Solutions partner up with PEAK Impact Program

News
Article

The program allows practices to sign up for rebate deals and discounted services.

Two businessmen shaking hands with overlay of business meeting graphic Image Credit: AdobeStock/ImageFlow

Image Credit: AdobeStock/ImageFlow

Walman Optical has announced that with a partnership with ADO Practice Solutions comes the PEAK Impact Program, which provides benefits and rebates available for eye care practices.1

“The PEAK Impact Program is more than just a benefits package; it’s a cornerstone for practice empowerment,” said Glen Funk, senior vice president and general manager of Walman Optical, in a news release. “We are dedicated to providing resources that significantly lessen operational burdens, allowing our partners to concentrate on what they do best – exceptional patient care.”

Practices that decide to join the program are offered a variety of benefits including rebates on lab work and services, free shipping on all incremental frame orders, and savings on eye glasses and contact lenses, according to the release. The Walman optical and contact lens rebates, in addition to a Cooper Vision and Johnson and Johnson contact lens rebate, is billed, purchased, and points to ADO, respectively. The program consists of 3 different benefit levels: PEAK Essentials, PEAK Performance, and PEAK Accelerator, with marketing support provided through DONE4YOU.2

For PEAK Essentials, the 3 rebates are listed at 1% on all purchases, with participating practices needing to maintain active ADO membership and a $2,500 monthly private pay revenue to Walman Optical. For PEAK Performance, all rebates are listed at 3%, which also holds the same requires, in addition to being a client of the DONE4YOU Marketing Package Program client. PEAK Accelerator receives the same benefits as the Performance package, but also includes a $250 discount per month for marketing services, in addition to a $500 per month marketing campaign credit. The Accelerator program also requires an additional $5,000 in monthly private pay revenue to Walman Optical above its pre-program average, while maintaining ADO membership and DONE4YOU client status.2

For Walman’s lab services, the company has a network of 28 labs and 3 processing centers for its eyewear. The company also has a 5 day average turn time for eye wear.3

Practices interested in learning more about program enrollment can visit the Walman website.

References
  1. PEAK Impact Program: Revolutionizing eye care with unmatched benefits and rebates. News release. Walman Optical. May 13, 2024. Accessed May 17, 2024.
  2. PEAK Impact Program. Walman Optical. Accessed May 17, 2024. https://www.walmanoptical.com/peak-impact-program
  3. Our Labs. Walman Optical. Accessed May 17, 2024. https://www.walmanoptical.com/lab-capabilities/our-labs
Recent Videos
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Alysse Henkel, vice president of Research and inSights at The Vision Council, advised that expanding budget and mid-market frame options may help improve frames sales.
With an additional 10% increase in tariffs to China, and a 25% increase in tariffs in Canada and Mexico looming, the optical industry is anticipating to pay as much as double in tariff costs compared to last year.
Although 2025 is predicted to remain stable, the forecast for the optical industry still remains uncertain.
Steven T. Reed, OD, American Optometric Association's president, overviews the 2024 highlights and how the organization plans to extend success into 2025.
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
© 2025 MJH Life Sciences

All rights reserved.